← All Tennessee bills

SB1495Introduced in the Senate

AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.

Passed

Introduced by Ferrell Haile, District 18

What does this bill do?

Plain-English breakdown

Writing a plain-English summary of this bill… this can take a few seconds the first time.

Official description

As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

Where it stands

Effective date(s) 05/05/2026

May 18, 2026

How did lawmakers vote?

House votes

1 recorded vote · each counted separately

Senate votes

2 recorded votes · each counted separately

HouseStage: FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION · April 16, 2026

87

Yes

0

No

1

Absent or Not Voting

88 representatives recorded in this House vote. Colors show vote categories only, not whether a vote was good or bad.

See how each representative voted

Bill history

  1. Filed for introduction

  2. Introduced, Passed on First Consideration

  3. Passed on Second Consideration, refer to Senate Judiciary Committee

  4. Placed on Senate Judiciary Committee calendar for 2/10/2026

  5. Recommended for passage, refer to Senate Calendar Committee

  6. Placed on Senate Consent Calendar 2 for 2/19/2026

  7. Passed Senate, Ayes 31, Nays 0

  8. Engrossed; ready for transmission to House

  9. Rcvd. from S., held on H. desk.

  10. Subst. for comp. HB.

  11. Passed H., Ayes 87, Nays 0, PNV 1

  12. Enrolled and ready for signatures

  13. Signed by Senate Speaker

  14. Signed by H. Speaker

  15. Transmitted to Governor for action.

  16. Signed by Governor.

  17. Pub. Ch. 888

  18. Effective date(s) 05/05/2026

Verify the information

Our commitment to neutrality

We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.